Trending, unpaywalled analysis
weekly look into what’s happening in the East. This time, she goes deep into the Olympics, Bonds, US-China relations and more.
In his monthly recap note, Gautam Jain, provides a performance update of his trade recommendations in emerging markets FX and rates.
Exclusive, in-depth analysis commissioned by Smartkarma
In the Second of this Three part SK Originals series, we discuss how China’s Company Accounting Standard No. 14 - Revenue (“CAS No. 14”) could impact the revenue recognition policy of Qi An Xin Technology Group 688561.CH
In this Original, Insight Provider Criss Wang
goes deep into several investment opportunities in the Health Care Equipment and Services category in China, such as Shenzhen Mindray Bio-Medical Electronics $300760.CH, and Ovctek China Inc $300595.CH
RSVP to join upcoming events. Subscribe for recordings
On 9 February, 5pm SGT, join our webinar with Kyle Rudden, who will speak about the problems with ESG Data and how the situation is improving as investor demand and regulations drive change.
The most interesting tweets of the week